DFFVX
Price
$34.03
Change
-$0.45 (-1.31%)
Updated
Sep 20 closing price
JSVQX
Price
$29.65
Change
-$0.42 (-1.40%)
Updated
Sep 20 closing price
Ad is loading...

DFFVX vs JSVQX

Header iconDFFVX vs JSVQX Comparison
Open Charts DFFVX vs JSVQXBanner chart's image
DFA US Targeted Value I
Price$34.03
Change-$0.45 (-1.31%)
VolumeN/A
CapitalizationN/A
JPMorgan Small Cap Value R4
Price$29.65
Change-$0.42 (-1.40%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
DFFVX vs JSVQX Comparison Chart
Loading...
VS
DFFVX vs. JSVQX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DFFVX is a Buy and JSVQX is a StrongBuy.

FUNDAMENTALS
Fundamentals
DFFVX has more cash in the bank: 13.8B vs. JSVQX (1.36B). DFFVX pays higher dividends than JSVQX: DFFVX (1.37) vs JSVQX (1.26). DFFVX was incepted earlier than JSVQX: DFFVX (25 years) vs JSVQX (8 years). JSVQX is a more actively managed with annual turnover of: 79.00 vs. DFFVX (20.00). DFFVX (0) and JSVQX (0) have matching initial minimum investment requirements. JSVQX annual gain was more profitable for investors over the last year : 26.20 vs. DFFVX (22.61). DFFVX return over 5 years is better than : 59.42 vs. JSVQX (20.68).
DFFVXJSVQXDFFVX / JSVQX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence25 years8 years-
Gain YTD7.51410.46972%
Front LoadN/AN/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets13.8B1.36B1,014%
Annual Yield % from dividends1.371.26109%
Returns for 1 year22.6126.2086%
Returns for 3 years20.03-7.66-261%
Returns for 5 years59.4220.68287%
Returns for 10 years55.75N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BHVN40.39-0.03
-0.07%
Biohaven Ltd
FNA6.87-0.01
-0.15%
Paragon 28
GIB112.76-1.07
-0.94%
CGI
CMPX1.68-0.05
-2.89%
Compass Therapeutics
CPIX1.24-0.04
-3.12%
Cumberland Pharmaceuticals